Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VIMIZIM safely and effectively. See full prescribing information for VIMIZIM. VIMIZIM (elosulfase alfa) injection, for intravenous use Initial U.S. Approval: 2014
Medication labelWhy this: Advisory · dailymed-prescription
VIMIZIM (elosulfase alfa) is indicated for patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome).
- generic_name
- elosulfase alfa
- product_names
- elosulfase alfa
- ndc
- 68135-100, 68135-100-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en